Saccharomyces boulardii cncm i-745
Ultra-Levura 250 MG Polvo Para Suspension Oral
Packs
| Pack | Code | Status |
|---|---|---|
| ULTRA-LEVURA 250 MG POLVO PARA SUSPENSION ORAL , 10 sobres | 700754 | |
| ULTRA-LEVURA 250 MG POLVO PARA SUSPENSION ORAL , 20 sobres | 700755 |
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Saccharomyces boulardii cncm i-745
- Strength
- 250 mg
- Dosage form
- polvo para suspensión oral
- Route
- vía oral
- Register
- Spain (AEMPS)
- Status
- Marketed
- Status in the register
- Autorizado, comercializado
- Authorised
- 4 Dec 2013
- Registration
- 78258
- Marketing authorisation holder
- Biocodex
- Procedure
- National, MRP or DCP
- Supply
- Sin Receta